LEADER 04869nam 2201153z- 450 001 9910566484903321 005 20220506 035 $a(CKB)5680000000037530 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/80986 035 $a(oapen)doab80986 035 $a(EXLCZ)995680000000037530 100 $a20202205d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aDisruptive Behavior Disorders$eSymptoms, Evaluation and Treatment 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (210 p.) 311 08$a3-0365-3628-0 311 08$a3-0365-3627-2 330 $aDisruptive behavior disorders (DBD) refer to a group of conditions that typically share difficulties in modulating aggressive conducts, self-control, and impulses, with resulting behaviors that constitute a threat to others' safety and to social norms. Problematic issues with self-control associated with these disorders are commonly first observed in childhood, but may often persist into adolescence and adulthood, or pose a developmental risk for subsequent negative outcomes. The clinical management of DBD in childhood and adolescence has seen great advances in recent years, and research has also focused on identifying early signs, predictors, and risk factors, which may help clinicians to disentangle and subtype the heterogeneous manifestations of BDB. This has allowed significant progress to be made in defining specific developmental trajectories, targeted prevention programs, and timely treatment strategies. The principal aims of this Special Issue were thus to address three core features of DBD clinical management, the multidimensional assessment of callous-unemotional traits, empathic faults and emotional dysregulation, and the available treatment options. In this Special Issue, twelve relevant contributions, including ten original articles, one systematic review, and one study protocol, which provide novel insights for the assessment and treatment of DBD in clinical practice, have been collected by the editors. 517 $aDisruptive Behavior Disorders 606 $aMedicine and Nursing$2bicssc 606 $aMental health services$2bicssc 610 $aacute placebo-controlled single-blind challenge clinical trial 610 $aADHD 610 $aADHD medications 610 $aadolescence 610 $aaggression 610 $aantisocial personality problems 610 $aautonomic functioning 610 $abig five personality traits model 610 $abipolar disorder 610 $abullying 610 $acallous-unemotional traits 610 $acallous-unemotional traits 610 $achildhood 610 $achildrearing 610 $acognitive-behavioral 610 $aconduct disorder 610 $aconduct problems 610 $aconscience development 610 $acontrol design 610 $aCoping Power 610 $acyberbullying 610 $aD2 receptor modulators 610 $adisruptive behavior 610 $adisruptive behavior disorders 610 $aemerging adulthood 610 $aemotion recognition 610 $aemotional and behavioral problems 610 $aempathy 610 $aexternalizing symptoms 610 $afamily functioning 610 $afearlessness 610 $aforgiveness 610 $agender 610 $agroup intervention 610 $aguilt 610 $aimpulsivity 610 $amedications for aggression 610 $aMindful Coping Power 610 $amindfulness 610 $amoral disengagement 610 $amother rejection 610 $an/a 610 $aneuropsychological functioning 610 $anon-suicidal self-injuries 610 $aobsessive-compulsive problems 610 $aoppositional defiant disorder 610 $aparental warmth 610 $aparenting style 610 $apeer aggression 610 $aprevention 610 $apsychopathic traits 610 $areactive aggression 610 $aresponsibility 610 $aself-regulation 610 $asibling relationship 610 $asocial rules 610 $asocialization 610 $astructural equation modeling 610 $asubstance use 610 $asuicidality 610 $atheory of mind 610 $avalues 610 $aviolence 615 7$aMedicine and Nursing 615 7$aMental health services 700 $aMilone$b Annarita$4edt$01330871 702 $aSesso$b Gianluca$4edt 702 $aMilone$b Annarita$4oth 702 $aSesso$b Gianluca$4oth 906 $aBOOK 912 $a9910566484903321 996 $aDisruptive Behavior Disorders$93040004 997 $aUNINA